CheckMyRecalls

Siemens Healthcare Diagnostics, Inc. recalls Atellica CH Urine Albumin…

Siemens Healthcare Diagnostics, Inc. recalls Atellica CH Urine Albumin (UAlb)

Published
11 Mar 2026
Units affected
4,885 units
Agency
FDA
Country
United States

The hazard

Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

Atellica CH Urine Albumin (UAlb). Material Number: 11537225

Brand / company
Siemens Healthcare Diagnostics, Inc.
Codes / lots
Material Number: 11537225. UDI-DI: 00630414611099. Lot Numbers: All lot numbers.
Distribution
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Korea, Latvia, Malaysia, Netherlands, New Zealand, Norway, Portugal, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United¿Kingdom.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 11 Mar 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.